Old Web
English
Sign In
Acemap
>
authorDetail
>
Ivan C H Au
Ivan C H Au
University of Hong Kong
Internal medicine
Medicine
Hazard ratio
Coronavirus disease 2019
Lower risk
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: propensity score analysis of a territory-wide cohort in Hong Kong
2021
Diabetes & Metabolism
Carlos K. H. Wong
David T.W. Lui
Angel Y.C. Lui
Ashley C.Y. Kwok
Marshall C.H. Low
Kristy T K Lau
Ivan C H Au
Xi Xiong
Matthew S H Chung
Eric H. Y. Lau
Benjamin J. Cowling
Show All
Source
Cite
Save
Citations (0)
Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone.
2021
Clinical Infectious Diseases
Carlos K. H. Wong
Kristy T K Lau
Ivan C H Au
Xi Xiong
Matthew S H Chung
Eric H. Y. Lau
Benjamin J. Cowling
Show All
Source
Cite
Save
Citations (0)
Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.
2021
Clinical Infectious Diseases
Carlos K. H. Wong
Kristy T K Lau
Ivan C H Au
Xi Xiong
Eric H. Y. Lau
Benjamin J. Cowling
Show All
Source
Cite
Save
Citations (1)
1